Cognition and Imaging With Tigertriever
Recruiting · NCT05531461
Conditions: Stroke
At a glance
- Research payments reported, 2025
- $105,349
- U.S. investigators named
- 2
- Sites paid
- 5
- Planned or actual enrollment
- 424
About the trial
- Sponsor
- Rapid Medical
- Dates
- Started 2024-10-28; completion 2027-11
- Results posted
- Not yet
The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.
From ClinicalTrials.gov, last updated 2026-10-09. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Rapid Medical Ltd reported $105,349 in research payments for this study in 2025 (9 payments).
Products named: Tigertriever 17 Revascularization Device
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Satoshi Tateshima, MD Interventional Radiology · Los Angeles, CA
- Fawaz A. Al-mufti, MD Neurology · Valhalla, NY
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Spectrum Health $31,958
- UCLA Medical Center $22,141
- University of Texas Austin $17,760
- Westchester Medical Center, NY $16,990
- Willis Knighton Medical Center, LA $16,500
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.